Labcorp Holdings PE Ratio 2010-2025 | LH
Current and historical p/e ratio for Labcorp Holdings (LH) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Labcorp Holdings PE ratio as of July 18, 2025 is 16.55.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Labcorp Holdings PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-18 | 243.72 | 28.18 | |
| 2025-03-31 | 232.06 | $8.65 | 26.83 |
| 2024-12-31 | 228.00 | $8.82 | 25.85 |
| 2024-09-30 | 221.53 | $5.17 | 42.85 |
| 2024-06-30 | 201.10 | $5.28 | 38.09 |
| 2024-03-31 | 215.09 | $4.97 | 43.28 |
| 2023-12-31 | 223.04 | $4.67 | 47.76 |
| 2023-09-30 | 196.62 | $7.48 | 26.29 |
| 2023-06-30 | 202.08 | $9.27 | 21.80 |
| 2023-03-31 | 191.47 | $11.02 | 17.37 |
| 2022-12-31 | 195.95 | $13.86 | 14.14 |
| 2022-09-30 | 169.93 | $18.75 | 9.06 |
| 2022-06-30 | 193.91 | $20.90 | 9.28 |
| 2022-03-31 | 217.52 | $21.79 | 9.98 |
| 2021-12-31 | 259.22 | $24.38 | 10.63 |
| 2021-09-30 | 232.19 | $28.17 | 8.24 |
| 2021-06-30 | 227.58 | $29.29 | 7.77 |
| 2021-03-31 | 210.40 | $26.90 | 7.82 |
| 2020-12-31 | 167.93 | $15.81 | 10.62 |
| 2020-09-30 | 155.32 | $8.59 | 18.08 |
| 2020-06-30 | 137.04 | $3.67 | 37.34 |
| 2020-03-31 | 104.27 | $3.23 | 32.28 |
| 2019-12-31 | 139.57 | $8.36 | 16.69 |
| 2019-09-30 | 138.60 | $7.60 | 18.24 |
| 2019-06-30 | 142.64 | $8.45 | 16.88 |
| 2019-03-31 | 126.21 | $8.79 | 14.36 |
| 2018-12-31 | 104.25 | $8.60 | 12.12 |
| 2018-09-30 | 143.29 | $13.85 | 10.35 |
| 2018-06-30 | 148.11 | $12.49 | 11.86 |
| 2018-03-31 | 133.44 | $12.04 | 11.08 |
| 2017-12-31 | 131.60 | $12.21 | 10.78 |
| 2017-09-30 | 124.55 | $7.15 | 17.42 |
| 2017-06-30 | 127.17 | $7.12 | 17.86 |
| 2017-03-31 | 118.36 | $7.21 | 16.42 |
| 2016-12-31 | 105.91 | $6.92 | 15.31 |
| 2016-09-30 | 113.42 | $6.28 | 18.06 |
| 2016-06-30 | 107.47 | $6.06 | 17.73 |
| 2016-03-31 | 96.63 | $5.79 | 16.69 |
| 2015-12-31 | 102.00 | $4.25 | 24.00 |
| 2015-09-30 | 89.49 | $4.53 | 19.75 |
| 2015-06-30 | 100.01 | $4.63 | 21.60 |
| 2015-03-31 | 104.02 | $4.63 | 22.47 |
| 2014-12-31 | 89.02 | $5.93 | 15.01 |
| 2014-09-30 | 83.94 | $5.97 | 14.06 |
| 2014-06-30 | 84.48 | $6.01 | 14.06 |
| 2014-03-31 | 81.02 | $5.99 | 13.53 |
| 2013-12-31 | 75.38 | $6.24 | 12.08 |
| 2013-09-30 | 81.79 | $6.07 | 13.47 |
| 2013-06-30 | 82.58 | $5.97 | 13.83 |
| 2013-03-31 | 74.42 | $5.91 | 12.59 |
| 2012-12-31 | 71.46 | $5.98 | 11.95 |
| 2012-09-30 | 76.29 | $6.06 | 12.59 |
| 2012-06-30 | 76.40 | $5.84 | 13.08 |
| 2012-03-31 | 75.52 | $5.48 | 13.78 |
| 2011-12-31 | 70.93 | $5.08 | 13.96 |
| 2011-09-30 | 65.22 | $5.00 | 13.04 |
| 2011-06-30 | 79.85 | $5.03 | 15.88 |
| 2011-03-31 | 76.01 | $5.29 | 14.37 |
| 2010-12-31 | 72.53 | $5.31 | 13.66 |
| 2010-09-30 | 64.70 | $5.38 | 12.03 |
| 2010-06-30 | 62.16 | $5.25 | 11.84 |
| 2010-03-31 | 62.46 | $5.03 | 12.42 |
| 2009-12-31 | 61.74 | $5.00 | 12.35 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $20.399B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.013B | 25.51 |
| CVS Health (CVS) | United States | $78.381B | 9.74 |
| Elevance Health (ELV) | United States | $62.604B | 8.39 |
| Cencora (COR) | United States | $56.765B | 19.75 |
| DiDi Global (DIDIY) | China | $26.874B | 28.55 |
| Natera (NTRA) | United States | $18.966B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.991B | 0.00 |
| CochLear (CHEOY) | Australia | $13.143B | 0.00 |
| Solventum (SOLV) | United States | $12.678B | 13.42 |
| ICON (ICLR) | Ireland | $11.592B | 10.78 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| Viatris (VTRS) | United States | $10.422B | 3.58 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| Medpace Holdings (MEDP) | United States | $8.964B | 23.81 |
| Sonic Healthcare (SKHHY) | Australia | $8.852B | 0.00 |
| HealthEquity (HQY) | United States | $8.449B | 37.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.680B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.587B | 14.87 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.918B | 28.96 |
| BrightSpring Health Services (BTSG) | United States | $3.506B | 32.17 |
| Sotera Health (SHC) | United States | $3.139B | 17.84 |
| Surgery Partners (SGRY) | United States | $2.861B | 37.20 |
| Concentras Parent (CON) | United States | $2.507B | 14.49 |
| Organon (OGN) | United States | $2.459B | 2.61 |
| Alignment Healthcare (ALHC) | United States | $2.455B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.222B | 85.57 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| PACS (PACS) | United States | $1.823B | 0.00 |
| Premier (PINC) | United States | $1.725B | 13.09 |
| GoodRx Holdings (GDRX) | United States | $1.672B | 33.43 |
| Ardent Health (ARDT) | United States | $1.589B | 6.77 |
| Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.277B | 438.00 |
| Establishment Labs Holdings (ESTA) | $1.202B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.080B | 8.22 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.878B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.759B | 7.10 |
| CareDx (CDNA) | United States | $0.663B | 10.36 |
| Nutex Health (NUTX) | United States | $0.632B | 9.57 |
| So-Young (SY) | China | $0.595B | 0.00 |
| SBC Medicals (SBC) | United States | $0.585B | 0.00 |
| Embecta (EMBC) | United States | $0.572B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| LifeMD (LFMD) | United States | $0.479B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.402B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.12 |
| Oncology Institute (TOI) | United States | $0.312B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.297B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.146B | 0.00 |
| DocGo (DCGO) | United States | $0.146B | 23.83 |
| Sera Prognostics (SERA) | United States | $0.110B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| KindlyMD (NAKA) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| ModivCare (MODV) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |